Sano Genetics hosted Episode 255 of The Genetics Podcast featuring Patrick and Dr. Danny Miller discussing long-read sequencing, building a long-read reference dataset, and genome-informed care.
Public source
Publisher name
Public post
🎙️Episode 255 of #TheGeneticsPodcast is live! 🚀 This week, Patrick is joined by Dr. Danny Miller, Assistant Professor of Pediatrics and Laboratory Medicine and Patholo…
Company
Sano Genetics
Accelerating the world's transition to precision medicine.
- Industry
- Biotechnology Research
- Location
- Cambridge, GB
- Company size
- 11–50 employees
About Sano Genetics
At Sano, our mission is to accelerate the world's transition to precision medicine. Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients.
See moreLatest activity
Latest activity from Sano Genetics
6 signals
Research & Knowledge
Sano Genetics notes that a new ResearchAndMarkets forecast places the decentralized clinical trial technology platform market at $3.37B in 2026, up from $2.9B the year before, reaching $6.12B by 2030 at roughly a 16% CAGR.
Research & Knowledge
Sano Genetics wrote about how the shift from treating rare disease trials as fixed costs of one study to infrastructure across programs and years changes the financial aspect of rare disease development.
Legal & Regulatory
Sano Genetics notes that the FDA recently opened the door a little wider for drugs to reach approval on a single clinical trial, with new draft guidance clarifying when a well-controlled trial can be enough to prove a drug works.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
PacBio
PacBio CEO Mark Van Oene joins Mendelspod's latest podcast to discuss newborn screening, genomic information from birth, and long-read sequencing.
Presence & Recognition
Singleron Biotechnologies
Singleron Biotechnologies hosted a podcast featuring Deniz Sinar discussing AI transforming biological data analysis and coding for researchers.
Presence & Recognition
PrecisionLife
PrecisionLife shared an episode of BiologyMatters discussing long COVID and ME/CFS research with Open Medicine Foundation
Presence & Recognition
Touchlight
Touchlight featured two leading experts in The Great DNA Debate: Plasmid vs. Cell-Free DNA to unpack real-world data, practical use cases, and fresh perspectives on genetic medicine.
Presence & Recognition
Pan.bio